| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2009 | US20090011032 Methods for improved cryo-chemotherapy tissue ablation |
| 01/08/2009 | US20090011030 Breakthrough pain management |
| 01/08/2009 | US20090011024 Pharmaceutical compositions of dispersions of amorphous drugs mixed with polymers |
| 01/08/2009 | US20090011023 Chemotherapeutic compositions |
| 01/08/2009 | US20090011020 Gastroresistant Pharmaceutical Formulations Containing Rifaximin |
| 01/08/2009 | US20090011018 Sustained release formulation for tacrolimus |
| 01/08/2009 | US20090011016 Crush-Resistant Oxycodone Tablets Intended For Preventing Accidental Misuse And Unlawful Diversion |
| 01/08/2009 | US20090011014 Tablet Formulation for Sustained Drug-Release |
| 01/08/2009 | US20090011013 Tacrolimus Combination Products |
| 01/08/2009 | US20090011012 Fatty acid compositions and methods of use |
| 01/08/2009 | US20090011011 Stable dosage formulations of imidazolylalkyl-pyridines |
| 01/08/2009 | US20090011010 Controlled release and taste masking oral pharmaceutical composition |
| 01/08/2009 | US20090011007 Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water |
| 01/08/2009 | US20090011006 Once daily formulations of tetracyclines |
| 01/08/2009 | US20090011005 Pharmaceuticals compositions containing nanomaterials useful for treating restenotic lesions |
| 01/08/2009 | US20090011004 Improved carriers for delivery of nucleic acid agents to cells and tissues |
| 01/08/2009 | US20090011003 Composition for Suppressing Expression of Target Gene |
| 01/08/2009 | US20090011001 Manufacturing process for liposomal preparations |
| 01/08/2009 | US20090010999 Complex Particles and Coated Complex Particles |
| 01/08/2009 | US20090010992 Drug formulations for oral transmucosal delivery to pediatric patients |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010968 Spot-on formulation useful for cosmetology and dermatology |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010952 Pharmaceutical compound for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt or erp57 translocation |
| 01/08/2009 | US20090010951 Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same |
| 01/08/2009 | US20090010949 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 01/08/2009 | US20090010944 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | US20090010941 Methods for treating HIV |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |
| 01/08/2009 | US20090010936 Novel Stra6 Polypeptides |
| 01/08/2009 | US20090010935 Compositions and Methods of Treating Tumors |
| 01/08/2009 | US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors |
| 01/08/2009 | US20090010932 Gb virus c (hepatitis g virus) for the treatment of hiv |
| 01/08/2009 | US20090010929 Therapeutic Antibodies, Antibody Fragments and Antibody Conjugates |
| 01/08/2009 | US20090010927 Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells |
| 01/08/2009 | US20090010923 Treatment of cancer with anti-muscarinic receptor agents |
| 01/08/2009 | US20090010919 Diagnostics and Therapeutics for Diseases Associated With Fibroblast Activation Protein (Fap) |
| 01/08/2009 | US20090010914 Use of Oligouronates for Treating Mucus Hyperviscosity |
| 01/08/2009 | US20090010909 Novel GPCR and methods of use of the same |
| 01/08/2009 | US20090010908 Materials and Methods for Diagnosis and Treatment of Chronic Fatigue Syndrome |
| 01/08/2009 | US20090010906 Peroral dosage forms to achieve a sustained-release effect after medicament dosage with a meal |
| 01/08/2009 | US20090010904 Immunostimulating Agent and Method for Production Thereof |
| 01/08/2009 | US20090010894 Methods and systems for identifying compounds that modulate alpha-synuclein aggregation |
| 01/08/2009 | US20090010888 Use of cytochrome P450 reductase as insecticidal target |
| 01/08/2009 | US20090010887 Method and composition for enhancing anti-angiogenic therapy |
| 01/08/2009 | US20090010886 Method for the Treatment of Myeloproliferative Diseases Using(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2- Methylsulfonylethyl]-4- Acetylaminoisoindoline-1,3- Dione |
| 01/08/2009 | US20090010885 Methods for Detecting and Treating Autoimmune Disorders |
| 01/08/2009 | US20090010884 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 01/08/2009 | US20090010883 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of metastatic gastric or stomach cancer |
| 01/08/2009 | US20090010882 Polymorphs of sodium 4-4[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 01/08/2009 | US20090010881 Using endothelial growth factor specific immunoglobulin as therapeutic tool in treatment of bladder cancer |
| 01/08/2009 | US20090010880 2-Amino-2,7-dideoxy-alpha-D-glycero-D-gluco-heptopyranosyl Inhibitors of Positive Sense Single-Stranded RNA Envelope Viruses |
| 01/08/2009 | US20090010878 Pulsatile dosing of gossypol for treatment of disease |
| 01/08/2009 | US20090010877 Methods for treatment prostate cancer using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/08/2009 | US20090010876 Visfatin and uses thereof |
| 01/08/2009 | US20090010873 Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis |
| 01/08/2009 | US20090010871 Method for Production of a Transformed Cell |
| 01/08/2009 | US20090010870 Hydrophobic Flourinated Polymer Surfaces |
| 01/08/2009 | US20090010869 Compositions for Topical Enzymatic Debridement |
| 01/08/2009 | US20090010867 Skin Cleansing Composition |
| 01/08/2009 | US20090010865 Process for Preparing Polymers in Aqueous Solvents |
| 01/08/2009 | US20090010861 Modified Plant Gums for Preparations of Active Ingredients |
| 01/08/2009 | US20090010860 used for protecting human hair and skin against the damaging effect of ultraviolet radiation |
| 01/08/2009 | US20090010850 Formulations and methods for treating dry eye |
| 01/08/2009 | US20090010845 Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery |
| 01/08/2009 | US20090010842 Methods for the early diagnosis of ovarian cancer |
| 01/08/2009 | DE202008007463U1 Nikotinteebeutel Nicotine teabag |
| 01/08/2009 | DE102007032158A1 Antitumormittel Antitumor agents |
| 01/08/2009 | DE102007031452A1 Feuchtigkeitsspendende kosmetische und dermatologische Zusammensetzungen mit Enhancern Moisturizing cosmetic and dermatological compositions with enhancers |
| 01/08/2009 | DE102007030695A1 Co-crystal, useful e.g. to prepare a pharmaceutical formulation for the treatment of psychosis, neurological disorder and struma lymphomatosa, comprises an amino compound and urea as further component |
| 01/08/2009 | DE102006014324B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 01/08/2009 | DE102006014319B4 Inhibitoren der löslichen Adenylatzyklase Inhibitors of soluble adenylate cyclase |
| 01/08/2009 | DE102005054700B4 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 01/08/2009 | CA2729006A1 Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration |
| 01/08/2009 | CA2728985A1 Modulators of atp-binding cassette transporters for treating cystic fibrosis |
| 01/08/2009 | CA2728366A1 Small molecule correctors of deltaf508 cftr trafficking |
| 01/08/2009 | CA2699965A1 Pet probe having an alkoxy group substituted by fluorine and hydroxy group |
| 01/08/2009 | CA2695031A1 Novel substituted piperidones as hsp inducers |
| 01/08/2009 | CA2694354A1 Lactic acid bacteria-derived double-stranded rna |
| 01/08/2009 | CA2694284A1 Heterocyclic compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2694264A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2694253A1 Substituted piperazines as cb1 antagonists |
| 01/08/2009 | CA2694242A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 01/08/2009 | CA2693182A1 Compounds useful as raf kinase inhibitors |
| 01/08/2009 | CA2693072A1 Orally disintegrating tablet compositions of lamotrigine |
| 01/08/2009 | CA2693032A1 Nmda receptor antagonists for neuroprotection |
| 01/08/2009 | CA2692572A1 Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 01/08/2009 | CA2692513A1 Indane-amine derivatives, their preparation and use as medicaments |
| 01/08/2009 | CA2692506A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692503A1 Dsrna for treating viral infection |
| 01/08/2009 | CA2692502A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | CA2692493A1 Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs |
| 01/08/2009 | CA2692478A1 Treatment of influenza |
| 01/08/2009 | CA2692460A1 Novel hiv reverse transcriptase inhibitors |
| 01/08/2009 | CA2692448A1 A method of treating amblyopia |
| 01/08/2009 | CA2692419A1 Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
| 01/08/2009 | CA2692417A1 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 01/08/2009 | CA2692383A1 New chemical compounds |
| 01/08/2009 | CA2692379A1 Antiproliferative compounds based on 5-membered heterocycles |
| 01/08/2009 | CA2692355A1 Production and purification of esters of polyunsaturated fatty acids |